mutations
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
mutations
Jun 26, 2024, 13:27 |
Societies
Erman Akkus: Germline mutations are common in non-familial pancreatic cancer
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X: "Germline mutations…
Sep 13, 2023, 15:21 |
Insight
Justin Stebbing: Our study in Nature Communications has been highlighted by lots of news outlets focusing on age of first pregnancy as a major risk for breast cancer, and how we explain this via clonal patches in tissues.
Jul 30, 2023, 17:03 |
Insight
Evolution of the estrogen receptor as a therapeutic target for breast cancer - Marie Will
The hormone receptor oestrogen receptor-α (ER) orchestrates physiological mammary gland development, breast carcinogenesis and the…
Jul 23, 2023, 16:19 |
Blog
The first oral SERD gets closer to Europe - Paolo Tarantino
Positive CHMP opinion on the marketing authorization of elacestrant for patients with HR+/HER2- MBC with…
Jul 14, 2023, 19:22 |
Blog
Excited to share our analysis of 3,600 “real world” cases of Small Cell Lung Cancer (SCLC) - Christine M. Lovly
Out now in Cancer Discovery– excited to share our analysis of 3,600 “real world” cases…
All:
5
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube